"Massive image-based single-cell profiling reveals high levels of circulating platelet aggregates in patients with COVID-19", doi:10.1038/s41467-021-27378-2, Open Access
The paper itself says that blood thinners are already recommended for Covid patients.
"In response to a number of reports that anticoagulant therapy with heparin leads to better prognosis in COVID-19 patients, both domestic and international organizations have issued clinical practice guidelines recommending that all hospitalized COVID-19 patients should receive thromboprophylaxis (mainly heparin treatment) even without clear symptoms of thrombotic complications and understanding their efficacy."
Yep - it was clear from the beginning that hospitalized patients throw a ton of clots, so it's been in the guidelines since 2020 to treat anyone presenting with Covid symptoms with prophylactic thinners;
> Hospitalized nonpregnant adults with COVID-19 should receive prophylactic dose anticoagulation (AIII) (see the recommendations for pregnant individuals below). Anticoagulant or antiplatelet therapy should not be used to prevent arterial thrombosis outside of the usual standard of care for patients without COVID-19 (AIII).
From what I understand, there doesn't seem to be much benefit for overall treatment of the disease (e.g. sick people's lungs don't get better more quickly) but it's preventing tons of PEs and strokes so that's obviously very valuable.
I was thinking more like the affect of thinners already in use on a person (such as myself) if they get the rona, and how it affects disease progression.
"...Moreover, the group observed that the conversion time of SARS-CoV-2 PCR test results from positive to negative among aspirin-using COVID-positive patients was significantly shorter, and the disease duration was two-three days shorter, depending upon the patients' pre-existing conditions."
https://www.nature.com/articles/s41467-021-27378-2